The healthcare side of the coin maintained a steady, high-volume contour with market activity ranging from introducing new wearable devices to therapeutics and digital clinician tools. The Netherlands’ ViCentra ( €72.4M Series D) scaled its next-gen insulin pump, the Kaleido 2, and Belgium’s MRM Health ( €55M Series B) advanced microbiome therapeutics.While AI added horizontal layers of integration, the pillars of the market that remained stable through September were health technologies and climate infrast ...